References
- O’BrartDPLohmannCPKlonosGThe effects of topical corticosteroids and plasmin inhibitors on refractive outcome, haze, and visual performance after photorefractive keratectomy: a prospective, randomized, observer-masked studyOphthalmology19941019156515747522315
- ArasCOzdamarAAktunçRErçikanCThe effects of topical steroids on refractive outcome and corneal haze, thickness, and curvature after photorefractive keratectomy with a 6.0-mm ablation diameterOphthalmic Surg Lasers19982986216279715485
- BaekSHChangJHChoiSYKimWJLeeJHThe effect of topical corticosteroids on refractive outcome and corneal haze after photorefractive keratectomyJ Refract Surg19971376446529427202
- VetrugnoMMainoAQuarantaGMCardiaLThe effect of early steroid treatment after PRK on clinical and refractive outcomesActa Ophthalmol Scand2001791232711167281
- NobleSGoaKLLoteprednol etabonate: clinical potential in the management of ocular inflammationBio Drugs1998104329339
- HollandEJBartlettJDPaternoMRUsnerDWComstockTLEffects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteersCornea2008271505518245967
- BartlettJDHorwitzBLaibovitzRIntraocular pressure response to loteprednol etabonate in known steroid respondersJ Ocul Pharmacol1993921571658345288
- Lotemax product insert Available from: http://www.bausch.co.nz/en_US/downloads/ecp/pharma/general/lotemaxinsert.pdfAccessed May 21, 2011
- HowesJFBaruHVeredMNeumannRLoteprednol etabonate: comparison with other steroids in two models of intraocular inflammationJ Ocul Pharmacol19941012892938207332
- SamudreSSLattanzioFAJrWilliamsPBSheppardJDJrComparison of topical steroids for acute anterior uveitisJ Ocul Pharmacol Ther200420653354715684812
- Loteprednol Etabonate US Uveitis Study GroupControlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitisAm J Ophthalmol1999127553754410334346
- StewartRHorwitzBHowesJNovackGDHartKDouble-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. Loteprednol Etabonate Post-operative Inflammation Study Group 1J Cataract Refract Surg19982411148014899818338
- HollandEJDjalilianARSandersonJPAttenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantationCornea200928101139114319770719
- SteinRPhotorefractive keratectomyInt Ophthalmol Clin2000403355610941645
- GartyDSKerr MuirMGLohmannCPThe effect of topical corticosteroids on refractive outcome and corneal haze after photorefractive keratectomy: a prospective, randomized, double-blind trialArch Ophthalmol199211079449521637279
- CorbettMCO’BrartDPMarshallJDo topical steroids have a role following excimer laser photorefractive keratectomy?J Refract Surg19951153803878528917
- CantrillHLPalmbergPFZinkHAWaltmanSRPodosSMBeckerBComparison of in vitro potency of corticosteroids with ability to raise intraocular pressureAm J Ophthalmol1975796101210171173539
- NagyZZSzabóAKruegerRRSüvegesITreatment of intraocular pressure elevation after photorefractive keratectomyJ Cataract Refract